Disposition of Liposomal Daunorubicin During Cotreatment with Cytarabine in Patients with Leukaemia

By Pea F.  

Clinical Pharmacokinetics, Vol. 42, Iss. 9, 2003-01 ,pp. : 851-862

Adis International

Access to resources Recommend Favorite

Phase II, multicenter, randomized trial of CPX-351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AML

By Cortes Jorge E.   Goldberg Stuart L.   Feldman Eric J.   Rizzeri David A.   Hogge Donna E.   Larson Melissa   Pigneux Arnaud   Recher Christian   Schiller Gary   Warzocha Krzysztof   Kantarjian Hagop   Louie Arthur C.   Kolitz Jonathan E.  

Cancer, Vol. 121, Iss. 2, 2015-01 ,pp. : 234-242

Blackwell Publishing

Access to resources Recommend Favorite

Cytarabine/daunorubicin: Aortic thrombosis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1429, 2012-01 ,pp. : 14-15

Adis International

Access to resources Recommend Favorite

Cytarabine/daunorubicin: Neutropenia and hidradenitis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1395, 2012-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite

Cellular Uptake of Liposomal Daunorubicin and the Induction of Apoptosis

By Gray Atherton   Landfair Darla J.   Wiles Marc E.  

Drug Delivery, Vol. 6, Iss. 4, 1999-10 ,pp. : 213-226

Informa Healthcare

Access to resources Recommend Favorite